Digital Repository

Formulation changes and time trends in outcome following paraquat ingestion in Sri Lanka

Show simple item record

dc.contributor.author Wilks, M.F. en_US
dc.contributor.author Tomenson, J.A. en_US
dc.contributor.author Fernando, R. en_US
dc.contributor.author Ariyananda, P.L. en_US
dc.contributor.author Berry, D.J. en_US
dc.contributor.author Buckley, N.A. en_US
dc.contributor.author Gawarammana, I.B. en_US
dc.contributor.author Jayamanne, S. en_US
dc.contributor.author Gunnell, D. en_US
dc.contributor.author Dawson, A. en_US
dc.date.accessioned 2014-10-29T09:32:42Z
dc.date.available 2014-10-29T09:32:42Z
dc.date.issued 2011 en_US
dc.identifier.citation Clinical Toxicology(Phila); 49(1): pp.21-8 en_US
dc.identifier.issn 1556-3650 (Print) en_US
dc.identifier.issn 1556-9519 (Electronic) en_US
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/2080
dc.description.abstract INTRODUCTION: Deliberate self-harm with pesticides is a significant public health problem in rural Asia. We have previously shown an improved survival of patients with paraquat self-poisoning following the introduction of a new formulation with an increased emetic concentration, an alginate and a purgative in Sri Lanka. Further, formulation changes were introduced in October 2006; this study was designed to assess the impact of these changes on 6-week mortality following paraquat ingestion. METHODS: Prospective, cohort study of patients admitted with paraquat poisoning to 10 hospitals across Sri Lanka between September 2006 and September 2008. RESULTS: Overall, there was a significant (p < 0.001) increase in survival in the 533 patients included in this study compared to previous data (44.5 vs. 35.2% before September 2006 and 27.1% before October 2004). Patients ingesting the new INTEON formulation had a higher survival rate than those ingesting standard formulation (40.2 vs. 31.0%), but this effect was not statistically significant in Cox's proportional hazards model (hazard ratio 0.81, 95% CI 0.61?1.08 (unadjusted) and 1.17, 95% CI 0.82?1.68 (fully adjusted), respectively). CONCLUSIONS: This study has confirmed a continued improvement in survival of patients following self-harm with paraquat in Sri Lanka in recent years; however, in contrast to previous investigations, a beneficial effect associated with the INTEON formulation could not be substantiated. This may be partly due to the large number of patients in whom paraquat concentrations were too low for analytical confirmation of the formulation (n = 105) and who had a very high survival rate (86.7%).
dc.publisher Informa Healthcare en_US
dc.title Formulation changes and time trends in outcome following paraquat ingestion in Sri Lanka en_US
dc.type Article en_US
dc.identifier.department Medicine en_US
dc.creator.corporateauthor American Academy of Clinical Toxicology en_US
dc.creator.corporateauthor European Association of Poisons Centres and Clinical Toxicologists en_US
dc.description.note Indexed in MEDLINE en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account